Severe sinus bradycardia after initiation of bupropion therapy: A probable drug-drug interaction with metoprolol

Cardiovascular Drugs and Therapy

Volumn 18, Issue 4, 2004, Pages 329-330

  McCollum, David L ^a   Greene, Jerica L ^b   McGuire, Darren K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

bradycardia; bupropion; cytochrome P450; metoprolol

Indexed keywords

AMFEBUTAMONE; DILTIAZEM; METOPROLOL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DYSPNEA; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SINUS BRADYCARDIA; THORAX RADIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA, SINUS; BRADYCARDIA; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION;

EID: 4544388198     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000041254.15807.98     Document Type: Article

References (6)

1. Guzey C, Norstrom A, Spigset O. Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion. Therapeutic Drug Monitoring 2002;24:436-437.
2. Shad MU, Preskorn SH. A possible bupropion and imipramine interaction. J Clin Psychopharmacol 1997;118-119.
3. Nemeroff CB, Delane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-320.
4. Edeki TI, He H, Wood AJJ. Pharmacogenetic explanation for excessive B-blockade following timolol eye drops: Potential for oral-ophthalmic drug interaction. JAMA 1995;274:1611-1613.
5. Dinai Y, Mordechar S, Haveh N, Halkin H. Bradycardia induced by interaction between quinidine and ophthalmic timolol. Ann Intern Med 1985;103:890-891.
6. Weinshilboum R. Inheritance and Drug Response. N Engl J Med 2003;348:529-537.